Only 5 of 19 cities bidding to host the European Medicines Agency would attract enough current employees for operations to continue as normal. Moving to one of the 8 least popular cities risks permanent damage, the agency warns

The next €1B flagship projects will target ICT, energy and health, according to the draft work programme for 2018-2020 published by the Commission

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Paying hospitals for activity provides no incentive to improve. Using historical data, patients awaiting cardiac surgery can be profiled, with hospitals paid extra to bear the risk of complications, but receiving no further payment if a second operation is required